Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 - July 2021.

Joseph Y AbramsErmias D BelayShana Godfred-CatoAngela P CampbellLaura D ZambranoAmber KunkelAllison D MillerMichael J WuLu MengAmi B ShahMatthew E Oster

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

IVIG, steroids, and antiplatelet medication have become increasingly utilized as standard treatment for MIS-C patients, while the use of other treatments may be contingent on the type and severity of clinical findings.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
young adults
peritoneal dialysis
prognostic factors
case report
emergency department
adverse drug